Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
3.040
-0.170 (-5.30%)
At close: Oct 16, 2026, 4:00 PM EDT
3.020
-0.020 (-0.66%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $4.08 million as of October 16, 2026. It is the 45,797th most valuable company in the world and the 6,123rd biggest in the United States. Its market cap has decreased by 87.53% in one year.
Market Cap
4.08M
Enterprise Value
2.51M
1-Year Change
-87.53%
Global Rank
Country Rank
#6,123 United States
Category
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $4.08M, a decrease of -98.82%. That is a compound annual growth rate of -56.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 4.08M | -75.27% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 4.94M |
| Longeveron | 4.78M |
| Xenetic Biosciences | 4.71M |
| Enlivex | 4.46M |
| NuCana | 4.40M |
| Azitra | 4.33M |
| Lunai Bioworks | 4.16M |
| Jupiter Neurosciences | 4.14M |